Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure (Q28195769)

Europe PubMed Central

PubMed publication ID

12714200

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714200

Cardiology and cardiovascular medicine

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(02)00401-1

27 December 2023

author name string

Sergio Solis

0 references

Ananth Prasad

0 references

Jill Loupe

0 references

Kishore J. Harjai

1 reference

Europe PubMed Central

PubMed publication ID

12714200

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714200

full work available at URL

27 December 2023

language of work or name

English

0 references

publication date

April 2003

0 references

https://api.elsevier.com/content/article/PII:S0167527302004011?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(02)00401-1

https://api.elsevier.com/content/article/PII:S0167527302004011?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(02)00401-1

International Journal of Cardiology

27 December 2023

published in

0 references

volume

0 references

issue

2-3

0 references

page(s)

207-14

0 references

cites work

Chronic congestive heart failure. Where have we been? Where are we heading?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Nonsteroidal anti-inflammatory drugs and antihypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900401-1

7 January 2021

Identifiers